Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 45802-107

1 FDA label image from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Pseudoephedrine Hydrochloride (NDC 45802-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

054-rt-pseudoephedrine-hydrochloride-extended-release-tablets.jpg (054 Rt Pseudoephedrine Hydrochloride Extended Release Tablets)

054-rt-pseudoephedrine-hydrochloride-extended-release-tablets.jpg (054 Rt Pseudoephedrine Hydrochloride Extended Release Tablets)
Packaging label for Pseudoephedrine Hydrochloride Extended Release Tablets 120 mg, a nasal decongestant by Padagis Israel Pharmaceuticals Ltd. The box contains 10 coated caplets and highlights 12-hour sinus relief. The label includes dosing information, drug facts, warnings, and a comparison to Sudafed Sinus Congestion 12 Hour active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.